Interpace Diagnostics Group Inc. buy melinda
Start price
23.10.17
/
50%
€12.27
Target price
26.12.17
€15.33
Performance (%)
-30.88%
End price
26.12.17
€8.48
Summary
This prediction ended on 26.12.17 with a price of €8.48. The BUY prediction by melinda for Interpace Diagnostics Group Inc. performed very badly with a performance of -30.88%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Interpace Diagnostics Group Inc. | - | - | - | - |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% | 59.395% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% | 85.679% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% | 57.349% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% | 58.964% |
Comments by melinda for this prediction
In the thread Interpace Diagnostics Group Inc. diskutieren
Secteur.Services Business-Support
Diagnose Interpace vorhanden wichtige Daten in der Gastroenterologie - Weltkongress des American College of Gastroenterology (ACG) 2017
Präsentationen PancraGEN® BarreGEN® und vom Kollegium angenommen
(Vom Mitglied beendet)
Stopped prediction by melinda for Interpace Diagnostics Group Inc.
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€13.60
23.10.17
23.10.17
€17.00
26.12.17
26.12.17
-30.88%
26.12.17
26.12.17
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€8.03
29.06.17
29.06.17
€15.33
24.08.17
24.08.17
40.45%
24.08.17
24.08.17
Interpace Diagnostics Group Inc.
Start price
Target price
Perf. (%)
€20.32
07.04.17
07.04.17
€30.67
18.04.17
18.04.17
68.51%
18.04.17
18.04.17